A biased allosteric modulator functions as a molecular glue to induce β₂AR dimerization.

Area of Science:

• Pharmacology
• Structural Biology
• Biochemistry

Background:

• G-protein coupled receptors (GPCRs) are typically viewed as monomers, but evidence suggests dimerization influences signaling.
• Understanding GPCR dimerization mechanisms is crucial for developing targeted therapeutics.

Purpose of the Study:

• To investigate the mechanism of a β-arrestin-biased negative allosteric modulator, AP-7-168, on the β2-adrenergic receptor (β2AR).
• To explore the potential of ligand-induced dimerization as a strategy for GPCR modulation.

Main Methods:

• Cryo-electron microscopy (Cryo-EM) to determine the structural basis of AP-7-168 action.
• Cell-based assays to assess β2AR dimerization and nanocluster formation.
• Functional studies to evaluate signaling bias.

Main Results:

• AP-7-168 acts as a molecular glue, inducing β2AR homodimerization.
• Cryo-EM revealed AP-7-168 binding within transmembrane helices 3, 4, and 5, stabilizing a dimeric state.
• This dimeric conformation selectively prevents β-arrestin coupling and promotes nanocluster formation.

Conclusions:

• Ligand-induced GPCR dimerization is a viable mechanism for allosteric modulation.
• AP-7-168 provides a novel example of small-molecule-driven dimerization to bias GPCR signaling.
• This work highlights a new therapeutic avenue for modulating GPCR function.